Department of Pathology and Molecular Medicine, Wellington Sch Med, Wellington, New Zealand
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
J Clin Pathol. 2019 Sep;72(9):573-578. doi: 10.1136/jclinpath-2019-205959. Epub 2019 Jul 12.
The International Collaboration on Cancer Reporting (ICCR) has developed a suite of detailed datasets for international implementation. These datasets are based on the reporting protocols developed by the Royal College of Pathologists (UK), The Royal College of Pathologists of Australasia and the College of American Pathologists, with modifications undertaken by international expert groups appointed according to ICCR protocols. The dataset for the reporting of renal biopsy for tumour is designed to provide a structured reporting template containing minimum data recording key elements suitable for international use. In formulating the dataset, the ICCR panel incorporated recommendations from the 2012 Vancouver Consensus Conference of the International Society of Urological Pathology (ISUP) and the 2016 edition of the WHO Bluebook on tumours of the urinary and male genital systems. Reporting elements were divided into (Core) and (Non-core) components of the report. elements are as follows: specimen laterality, histological tumour type, WHO/ISUP histological tumour grade, sarcomatoid morphology, rhabdoid morphology, necrosis, lymphovascular invasion and coexisting pathology in non-neoplastic kidney. reporting elements are as follows: operative procedure, tumour site(s), histological tumour subtype and details of ancillary studies. In particular, it is noted that fluorescence in situ hybridisation studies may assist in diagnosing translocation renal cell carcinoma (RCC) and in distinguishing oncocytoma and eosinophilic chromophobe RCC. It is anticipated that the implementation of this dataset into routine clinical practice will facilitate uniformity of pathology reporting worldwide. This, in turn, should have a positive impact on patient treatment and the quality of demographic information held by cancer registries.
国际癌症报告协作组织(ICCR)已开发了一套详细的数据集,用于国际实施。这些数据集基于英国皇家病理学家学院(RCP)、澳大利亚皇家病理学家学院和美国病理学家学院制定的报告协议,由 ICCR 协议任命的国际专家组进行修改。用于报告肿瘤肾活检的数据集旨在提供一个结构化的报告模板,其中包含适合国际使用的最小数据记录关键要素。在制定数据集时,ICCR 小组纳入了国际泌尿病理学会(ISUP)2012 年温哥华共识会议和 2016 年版世界卫生组织泌尿系统和男性生殖系统肿瘤蓝皮书的建议。报告要素分为报告的 (核心)和 (非核心)部分。核心报告要素如下:标本侧位、组织学肿瘤类型、世界卫生组织/国际泌尿病理学会组织学肿瘤分级、肉瘤样形态、横纹肌样形态、坏死、血管淋巴管浸润和非肿瘤性肾脏共存病变。非核心报告要素如下:手术程序、肿瘤部位、组织学肿瘤亚型和辅助研究的详细信息。特别是,值得注意的是,荧光原位杂交研究可能有助于诊断易位性肾细胞癌(RCC),并区分嗜酸细胞性嫌色性 RCC 和嗜酸细胞瘤。预计将该数据集实施到常规临床实践中,将促进全球病理学报告的统一。这反过来又应该对患者的治疗和癌症登记处保存的人口统计学信息的质量产生积极影响。